SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates WRK, TGAN, ANSS, INBX
Inhibrx Inc Ordinary Shares INBX
News
-
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - HMST, FREE, EVBG, INBX
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates TAST, MDC, INBX
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates MDC, INBX, KAMN, HAYN
INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - INBX, KAMN, JNPR, HAYN
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INBX, BATL, KAMN
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AMAM, JNPR, INBX, RYZB
INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates INBX, KAMN, BATL
Kuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to Contact Law Firm
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates INBX, SP, WAVD, CATC
Unitholder Alert: Ademi LLP investigates whether Inhibrx, Inc. has obtained a Fair Price in its transaction with Sanofi
INBX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inhibrx, Inc. Is Fair to Shareholders
Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion — Update
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
Theft in open court: How a fight over lifesaving drugs led to charges of brazen industrial espionage
Inhibrx Granted FDA Fast Track Designation for INBRX-101